Tazzle (tadalafil) is a medication primarily used to treat erectile dysfunction (ED) and symptoms of benign prostatic hyperplasia (BPH). It belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors. Tadalafil, the active ingredient in Tazzle, does not directly affect blood glucose levels. Its primary mechanism of action involves inhibiting the enzyme PDE5, which leads to increased levels of cyclic guanosine monophosphate (cGMP) in smooth muscle cells. This results in relaxation of blood vessels and increased blood flow to certain areas of the body, which helps in achieving and maintaining an erection. While tadalafil primarily affects vascular function, it does not have a direct effect on glucose metabolism or insulin sensitivity. Therefore, Tazzle (tadalafil) is not expected to cause significant changes in blood glucose levels in individuals who use it for erectile dysfunction or BPH. However, it’s important to note that individuals with underlying health conditions such as diabetes may experience fluctuations in blood glucose levels due to factors unrelated to tadalafil use, such as stress, diet, or other medications.
Call: 876-927-9941–3 .
